Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aromatase Inhibitors”

443 trials

Showing 20 of 443 results

Not applicableNot Yet RecruitingNCT07409948
What this trial is testing

Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal Symptoms

Who this might be right for
Breast NeoplasmsMusculoskeletal PainArthralgia+3 more
Addis Ababa University 88
Not applicableStudy completedNCT01384838
What this trial is testing

Exercise Training in Postmenopausal Patients With Breast Cancer

Who this might be right for
Physical Activity
Arbeitsgemeinschaft medikamentoese Tumortherapie 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04544189
What this trial is testing

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Novartis Pharmaceuticals 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT01984138
What this trial is testing

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Who this might be right for
Estrogen Receptor Positive Breast CancerBreast Cancer
Polly A. Niravath, MD 33
Testing effectiveness (Phase 2)Study completedNCT03219476
What this trial is testing

Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer

Who this might be right for
Breast CancerInvasive Breast Cancer
Medical College of Wisconsin 37
Not applicableUnknownNCT05921617
What this trial is testing

A Cohort Study of Musculoskeletal Health in Patients With Breast Cancer During Aromatase Inhibitors Therapy

Who this might be right for
Musculoskeletal Health
Fudan University 870
Testing effectiveness (Phase 2)UnknownNCT04941885
What this trial is testing

Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-sen University 78
Not applicableStudy completedNCT00885612
What this trial is testing

10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

Who this might be right for
Breast Cancer
AstraZeneca 1,114
Large-scale testing (Phase 3)Study completedNCT01638247
What this trial is testing

Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients

Who this might be right for
Male Breast Cancer
GBG Forschungs GmbH 56
Testing effectiveness (Phase 2)Study completedNCT01082068
What this trial is testing

Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 72
Not applicableStudy completedNCT01050634
What this trial is testing

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)

Who this might be right for
Post Menopausal Women With Early Breast Cancer
Pfizer 980
Not applicableUnknownNCT05000736
What this trial is testing

Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC

Who this might be right for
Hormone Receptor Positive Advanced Breast Cancer
Chinese Academy of Medical Sciences 600
Not applicableStudy completedNCT00681122
What this trial is testing

CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)

Who this might be right for
Breast Cancer
AstraZeneca 2,600
Testing effectiveness (Phase 2)Ended earlyNCT00930527
What this trial is testing

Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors

Who this might be right for
Breast Cancer
Columbia University 10
Not applicableUnknownNCT02765373
What this trial is testing

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 500
Large-scale testing (Phase 3)Looking for participantsNCT05774951
What this trial is testing

Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Who this might be right for
Breast Cancer, Early Breast Cancer
AstraZeneca 4,300
Large-scale testing (Phase 3)Active Not RecruitingNCT00382070
What this trial is testing

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,966
Not applicableStudy completedNCT04176354
What this trial is testing

Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy

Who this might be right for
Metastatic Breast Cancer
Pfizer 813
Testing effectiveness (Phase 2)Ended earlyNCT00549822
What this trial is testing

Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 3
Early research (Phase 1)Study completedNCT03264651
What this trial is testing

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

Who this might be right for
Mammographic Density
Havah Therapeutics Pty Ltd 9
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation